Chau Quang Khuong
CIK 1609405 · last filed 2023-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.16M
Companies
8
Total Filings
70
Lifetime Open-Market Net
-$141.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NXTC | Director | 196,751 | $5.42 | $1.07M | $5.25M | 6 | 2023-06-23 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | 41,272 | $28.69 | $1.18M | $11.00M | 5 | 2023-06-15 |
| Fusion Pharmaceuticals Inc. (FUSN) Delisted | Director | 234,193 | $21.55 | $5.05M | $15.27M | 6 | 2023-06-14 |
| SYNLOGIC, INC. (SYBX) Delisted | Director | 246,444 | $0.69 | $170.0K | $0 | 7 | 2021-04-22 |
| INSP | Director | 1,875 | $51.97 | $97.4K | -$168.53M | 21 | 2020-10-13 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Director | 346,263 | $33.00 | $11.43M | $2.99M | 2 | 2019-06-19 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | 89,928 | $13.60 | $1.22M | $1.38M | 12 | 2017-10-27 |
| OTONOMY, INC. (OTIC) Delisted | Director | 1,850,684 | $0.08 | $142.5K | -$8.89M | 6 | 2016-06-21 |
Recent Filings · Page 4 of 7
70 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-15 | INSP | Grant (A) | +216 | $11.8K | EDGAR |
| 2019-07-17 | INSP | Grant (A) | +172 | $11.8K | EDGAR |
| 2019-06-19 | Whitehawk Therapeutics, Inc. (ARPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-17 | NXTC | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | SYNLOGIC, INC. (SYBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-13 | NXTC | Mixed | +2,711,013 | $5.25M | EDGAR |
| 2019-05-06 | INSP | Grant (A) | — | $0 | EDGAR |
| 2019-04-12 | INSP | Grant (A) | +213 | $11.8K | EDGAR |
| 2019-03-11 | INSP | Sell (S) | −358,449 | -$20.51M | EDGAR |
| 2019-01-14 | INSP | Grant (A) | +254 | $11.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.